Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease

Advances in Oto-Rhino-Laryngology

Volumn 62, Issue , 2005, Pages 161-172

  Kuss, I ^a   Hathaway, B ^a   Ferris, R L ^a   Gooding, W ^a   Whiteside, T L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FEMALE; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS;

EID: 16644384005     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (21)

1. Goldrath AW, Bevan MJ: Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255-262.
2. Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL: Decreased ζ chain expression and apoptosis in CD3+ peripheral T lymphocytes in patients with melanoma. Clin Cancer Res 2001;7:947-957.
3. Hoffmann T, Dworacki G, Tsukishiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 2002;8:2553-2562.
4. Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL: Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999;5:1263-1273.
5. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL: Signaling abnormalities, apoptosis, and reduced proliferation of circulation and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 2002;8:3137-3145.
6. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM: Directly measured kinetics of circulation T lymphocytes in normal and HIV-1-infected humans Nat Med 1999;5:83-89.
7. Neese RA, Siler SQ, Cesar D, Antelo F, Lee D, Misell L, Patel K, Tehrani S, Shah P, Hellerstein MK: Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation Anal Biochem 2001;298:189-195.
8. Reimann KA, O'Gorman MG, Spritzler J, Wilkening C, Sabath D, Helm K, Campbell D: Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: Evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. Clin Diagn Lab Immunol 2000;7:344-351.
9. Schroder W, Vering A, Stegmuller M, Strohmeier R: Lymphocyte subsets in patients with ovarian and breast cancer. Eur J Gynaecol Oncol 1997;18:474-477.
10. Wolf GT, Amendola BE, Diaz R, Lovett EJ, Hammerschmidt RM, Peterson KA: Definite vs adjuvant radiotherapy: Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma. Arch Otolaryngol 1985;111:716-726.
11. Melichar B, Touskova M, Solichova D, Kralickova P, Kopecky G: CD4+ T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours. Scand J Clin Lab Invest 2001;61:363-370.
12. Kay NE, Leong TL, Bone N, Vesole DH, Greipp PR, Van Ness B, Oken MM, Kyle RA: Blood levels of immune cells predict survival in myeloma patients: Results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood 2001;98:23-28.
13. Murta EF, de Andrade JM, Falcao RP, Bighetti S: Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 2000;86:403-407
14. Hernberg M, Muhonen T, Turunen JP, Hahka-Kemppinen M, Pyrohonen S: The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy. J Clin Oncol 1996;14:1690-1696.
15. Kuss I, Godfrey TE, Donnenberg AD, Whiteside TL: Low levels of T-cell receptor excision circles (TREC) and paucity of naïve T cells in the circulation of patients with cancer suggest a rapid lymphocyte turnover within the memory compartment. AACR Proc 2002;43:278.
16. Wolf GT, Schmaltz S, Hudson J, et al: Alterations in T lymphocyte subpopulations in patients with head and neck squamous carcinoma: Correlations with prognosis. Arch Otolaryngol 1987;113:1200-1206.
17. Friedman EJ: Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 2002;8:1765-1780.
18. Wolf GT, Bradford CR, Urba S, Smith A, et al: Immune reactivity does not predict immunotherapy response, organ preservation or survival in advanced laryngeal cancer. Laryngoscope 2002;112:1351-1356.
19. Kuss I, Donnenberg A, Gooding W, WhitesideTL: Effector CD8+CD45RO-CD27- T cells have signaling defects in patients with head and neck cancer. Br J Cancer 2003;88:223-230.
20. Tsukishiro T, Donnenberg AD, Whiteside TL: Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003;52:599-607.
21. Albers AE, Tsukishiro T, Ferris RL, DeLeo AB, Whiteside TL: TCR VB restrictions in peripheral circulation and tumor infiltrating lymphocytes obtained from patients with head and neck cancer. AACR Proc, Toronto, 2003, abstract 105839.